Reuters -- Teva Pharmaceutical Industries Ltd, the world's largest generic drugmaker, on Thursday set a target of revenue of $31 billion in 2015, more than double its current annual amount as it sees major growth in overall use of generics.
Reuters -- Teva Pharmaceutical Industries Ltd, the world's largest generic drugmaker, on Thursday set a target of revenue of $31 billion in 2015, more than double its current annual amount as it sees major growth in overall use of generics.
